Conference Coverage
Conference Coverage
Registry data favor CHOEP regimen for PTCL
LA JOLLA, CALIF. – Registry data have influenced the treatment of patients with PTCL in the Czech Republic.
Latest News
Soy didn’t up all-cause mortality in breast cancer survivors
The ongoing study tracks with previous work showing no risk from dietary soy.
Conference Coverage
Quick tips: How to get your study published
SAN DIEGO – Looking to get your study published in a top medical journal? Bob Löwenberg, MD, PhD, editor-in-chief of...
Conference Coverage
Tests can identify leukemia risk in newborns with Down syndrome
SAN DIEGO – These children face high rates of disease, and new research is shedding light on the reasons why.
Conference Coverage
Armored CAR protects T cells, induces remissions
SAN DIEGO – A CAR T-cell construct engineered to enhance T-cell persistence and immune function induced high complete remission rates in a phase 1...
Conference Coverage
Long-term side effects of CAR T cells mostly mild
SAN DIEGO – Follow-up of patients who survived at least 1 year after CAR T-cell infusions suggests that the technology is safe.
Conference Coverage
ALL chemotherapy looks effective in mixed phenotype leukemia
SAN DIEGO – In a retrospective cohort study, most children with mixed phenotype acute leukemia achieved MRD-negative complete response on ALL-...
Conference Coverage
Lenalidomide maintenance improves MCL survival after ASCT
SAN DIEGO – PFS was better post transplant with lenalidomide maintenance, but it’s too early to know whether OS will be improved.
Conference Coverage
Quizartinib improves survival of FLT3-mutated AML
SAN DIEGO – QuANTUM-R is the first randomized trial to show a survival benefit over salvage chemotherapy in patients with FLT3-ITD mutated AML.
Conference Coverage
Young women opt for mastectomy even when neoadjuvant chemo works well
SAN ANTONIO – Although neoadjuvant chemotherapy doubled the proportion of women eligible for breast-conserving surgery, about 40% chose mastectomy...
Conference Coverage
Older breast cancer patients given adjuvant chemo live longer
SAN ANTONIO – Overall survival is better in breast cancer patients aged 65 years and older who receive adjuvant chemotherapy, although patients...